Bulk anti-Human CD47 antibody (B6H12) - Low Endotoxin

Bulk anti-Human CD47 antibody (B6H12) - Low Endotoxin

Catalog Number:
A001437205ICH
Mfr. No.:
ICH1014
Price:
$680
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Specificity: Anti-CD47 In Vivo Antibody - Low Endotoxin (B6H12) recognizes an epitope on Human CD47
          Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
          Isotype Control: Mouse IgG1 Isotype Control for In Vivo - Low Endotoxin [HKSP] (ICH2247)
          Endotoxin: <1.0 EU/mg as determined by the LAL method
          Aggregation: Aggregation level ≤ 5%

          Please contact us at for specific academic pricing.

      • Properties
        • Host
          mouse
          Isotype
          IgG1 kappa
          Reactivity
          human
          Clone
          B6H12
          Immunogen
          Purified Recombinant Human CD47 (>98%)
          Purification
          >95% by SDS-PAGE and HPLC
          Formulation
          0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added.
          Storage
          anti-CD47 In Vivo Antibody - Low Endotoxin (B6H12) is stable when stored at 2-8°C. Do not freeze. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
          Molecular Weight
          1.0 - 5.0 mg/ml
          Regulatory Status
          Each investigator should determine their own optimal working dilution for specific applications.

          * Products are for research use only. Not for use in diagnostic or therapeutic procedures.

      • Applications
        • Application
          Flow Cytometry; Neutralization; Functional Assays; WB; Immunoprecipitation; Immunofluorescence; IHC (paraffin)

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.